Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI - Ep. 228
Jul 10, 2024
auto_awesome
Paige co-founder and AI expert Thomas Fuchs discusses how generative AI is transforming cancer diagnosis and treatment, improving patient outcomes. He explains the use of AI in analyzing pathology slides, detecting cancer, and enhancing precision in medical care. Fuchs also shares insights on the challenges and advancements in AI applications for healthcare, from pathology to space exploration.
Generative AI from Paige can enhance cancer diagnostics leading to better patient outcomes.
AI is revolutionizing healthcare in pathology and other specialties for personalized care and improved clinical outcomes.
Deep dives
Applications of AI in Pathology and Cancer Diagnosis
AI technology, like the one developed by Page, is revolutionizing cancer diagnosis by helping pathologists analyze digitized pathology slides. The AI tool can find and classify cancer, predict treatment responses and outcomes, and enhance pathologists' capabilities. Through large-scale training with millions of slides, collaborative efforts with Microsoft, and the use of advanced computer vision models, Page has achieved FDA approval and is making significant strides in cancer detection and classification.
Impact of AI in Healthcare and Medicine
AI's role in healthcare and medicine extends beyond pathology. At Mount Sinai, AI models are used in various specialties like cardiology, radiology, and psychiatry to drive research, early detection, and treatment decisions. The integration of AI in healthcare aims to provide personalized care, improve clinical outcomes, and address diagnostic errors that contribute to patient harm. The future of AI in healthcare involves scaling up AI applications, ensuring safety and effectiveness, and continuing to innovate in diagnostics and treatment.
Future of AI and Technical Advancements
The future of AI in healthcare and technical advancements hold promise for transformative breakthroughs. The focus on integrating AI tools into clinical settings is crucial for improving patient care and outcomes. Beyond language models, the complexity of biology and cancer research presents limitless opportunities for AI applications. By harnessing AI's power in analyzing cellular processes and developing new treatment strategies, the healthcare industry can achieve significant advancements in drug discovery, precision medicine, and patient care.
Improved cancer diagnostics — and improved patient outcomes — could be among the changes generative AI will bring to the healthcare industry, thanks to Paige, the first company with an FDA-approved tool for cancer diagnosis. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Paige cofounder and Chief Scientific Officer Thomas Fuchs. He’s also dean of artificial intelligence and human health at the Icahn School of Medicine at Mount Sinai.
Tune in to hear Fuchs on machine learning and AI applications and how technology brings better precision and care to the medical industry.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode